{
    "Trade/Device Name(s)": [
        "cobas\u00ae HCV for use on the cobas\u00ae 5800/6800/8800 Systems",
        "cobas\u00ae HCV"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K221007",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MZP"
    ],
    "Summary Letter Date": "April 4, 2022",
    "Summary Letter Received Date": "April 5, 2022",
    "Submission Date": "March 25, 2022",
    "Regulation Number(s)": [
        "21 CFR 866.3170"
    ],
    "Regulation Name(s)": [
        "ASSAY, HYBRIDIZATION AND/OR NUCLEIC ACID AMPLIFICATION FOR DETECTION OF HEPATITIS C RNA, HEPATITIS C VIRUS"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Hepatitis C virus (HCV) RNA"
    ],
    "Specimen Type(s)": [
        "EDTA Plasma",
        "Serum"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae 5800 System",
        "cobas\u00ae 6800 System",
        "cobas\u00ae 8800 System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid amplification",
        "Real-time PCR",
        "Automated nucleic acid extraction",
        "Dual detection probes",
        "Fluorescent reporter detection"
    ],
    "Methodologies": [
        "RT-PCR",
        "Real-time PCR",
        "Hybridization",
        "Automated molecular diagnostics"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System",
        "Automated system",
        "Software",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for cobas\u00ae HCV nucleic acid amplification assay for quantitative detection of hepatitis C virus RNA on cobas\u00ae 5800/6800/8800 Systems.",
    "Indications for Use Summary": "Quantitative nucleic acid test for detection and management of HCV RNA (genotypes 1-6) in EDTA plasma or serum from antibody-positive or HCV-infected individuals, aiding diagnosis and monitoring antiviral therapy response; not for blood donor screening.",
    "fda_folder": "Microbiology"
}